骨桥蛋白?CD44v6在胰腺癌中的表达及其与临床病理特征的关系
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

江苏省自然科学基金资助项目(BK2005157)


Co-expression of OPN,CD44v6 in pancreatic cancer and the relationship between their expression and clinicopathological characteristics
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨骨桥蛋白(OPN)与CD44v6在人胰腺癌中的表达,并分析OPN- CD44v6与胰腺癌临床病理特性的关系-方法:应用免疫组织化学方法检测OPN-CD44v6在43例胰腺癌-34例癌旁组织中的表达-结果:43例胰腺癌标本中OPN-CD44v6阳性表达率分别为65.1%-62.7%,34例胰腺癌旁组织OPN-CD44v6阳性表达率均为20.6%;有淋巴结转移的胰腺癌组织中OPN-CD44v6表达阳性率分别为86.7%-80.0%,无淋巴结转移者为53.5%-53.6%,二者相比差异均有显著性(P < 0.05);组织学分级为Ⅲ级的胰腺癌组织中CD44v6的表达率为85.7%,组织学分级为Ⅰ~Ⅱ级的胰腺癌组织中CD44v6的表达率为51.7%,二者相比差异有显著性(P < 0.05);CD44v6与OPN的表达呈正相关,相关系数r为0.446(P < 0.05)-结论: OPN-CD44v6在胰腺癌的浸润-转移中可能起重要作用,它们可作为胰腺癌浸润-转移及评估预后的指标-

    Abstract:

    Objective:To explore the expression of osteopontin(OPN), CD44v6 in human pancreatic carcinomas and analyze the relationship between their expression and clinicopathologic features. Methods:The expression of OPN,CD44v6 was tested by immunohistochemistry in 43 cases of pancreatic carcinomas,34 cases of pancreatic paraneoplastic tissues. Results:In 43 cases of pancreatic carcinomas, the expression rates of OPN,CD44v6 were 65.1%,62.7% respectively;in 34 cases of pancreatic paraneoplastic tissues, the expression rates of OPN and CD44v6 were 20.6% both. OPN and CD44v6 expression was higher in carcinomas with lymph node metastases than that without metastases; CD44v6 expression was higher in carcinomas with histological grade Ⅲ(P < 0.05) than that with Ⅰ~Ⅱ grade, and there were strong correlation between OPN and CD44v6(r = 0.446). Conclusion:The expressions of OPN and CD44v6 were higher in pancreatic carcinomas. They might play an important role in the progression of human pancreatic carcinomas and participat in the invasion and metastasis of pancreatic carcinomas.

    参考文献
    相似文献
    引证文献
引用本文

王维新,张国新,郝 波,朱 毅,徐泽宽.骨桥蛋白?CD44v6在胰腺癌中的表达及其与临床病理特征的关系[J].南京医科大学学报(自然科学版),2007,(8):801-803820

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2007-01-03
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
通知关闭
郑重声明